Abstract
The COVID-19 pandemic has not only led to a worldwide socio-economic depression, but has also had the highest health impact on the geriatric population. Elderly population, due to various reasons such as low immunity, pre-existing co-morbidities such as hypertension, cardiovascular diseases or diabetes, are obviously predisposed to develop severe infections and exhibit a high mortality rate. This is because of many reasons which include the atypical presentation in the geriatric population which might have led to diagnostic delay. As per the WHO guidelines to perform RT-PCR only on the symptomatic individuals, a very small portion of individuals were tested, leaving a fraction of population undiagnosed. Therefore, there remained a chance that many asymptomatic individuals such caregivers, healthcare professionals, family members were undiagnosed and might have carried this virus to the geriatric patients. Also, many countries were not prepared to handle the burden on their healthcare system which included sudden increased demand of ICU beds, mechanical ventilation etc. As a result, they had to make decision on who to be admitted. Atypical presentation in geriatric population may include afebrile or low-grade fever, absence of cough, malaise, muscle pains, dyspnoea etc. Geriatric population shows a more severe type of pneumonia, significantly higher number of neutrophils and C-reactive protein, less lymphocytes and a higher proportion of multiple lobe involvement. Extreme social suppression during COVID-19 pandemic has increased the risk of mental and physical adverse effects that has made older adults more vulnerable to depression and anxiety.
Research funding: None declared.
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
Competing interests: Authors state no conflict of interest.
Informed consent: Not applicable.
Ethical approval: Not applicable.
References
1. Li, Q, Guan, X, Wu, P, Wang, X, Zhou, L, Tong, Y, et al.. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382:1199–207.10.1056/NEJMoa2001316Search in Google Scholar
2. Chan, JF, Yuan, S, Kok, KH, To, KK, Chu, H, Yang, J, et al.. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020;395:514–23. https://doi.org/10.1016/s0140-6736(20)30154-9.Search in Google Scholar
3. Guo, YR, Cao, QD, Hong, ZS, Tan, YY, Chen, SD, Jin, HJ, et al.. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military Medical Research 2020;7:1. https://doi.org/10.1186/s40779-020-00240-0.Search in Google Scholar
4. Sahu, KK, Mishra, AK, Lal, A, Sahu, SA. India fights back: COVID-19 pandemic. Heart Lung 2020;49:446–8.10.1016/j.hrtlng.2020.04.014Search in Google Scholar PubMed PubMed Central
5. Singhal, T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr 2020:1–6.10.1007/s12098-020-03263-6Search in Google Scholar PubMed PubMed Central
6. Kochi, AN, Tagliari, AP, Forleo, GB, Fassini, GM, Tondo, C. Cardiac and arrhythmic complications in patients with COVID‐19. J Cardiovasc Electrophysiol 2020;31:1003–8. https://doi.org/10.1111/jce.14479.Search in Google Scholar
7. Zhu, H, Rhee, JW, Cheng, P, Waliany, S, Chang, A, Witteles, RM, et al.. Cardiovascular complications in patients with COVID-19: consequences of viral toxicities and host immune response. Curr Cardiol Rep 2020;22:1–9. https://doi.org/10.1007/s11886-020-01302-4.Search in Google Scholar
8. Payus, AO, Lin, CL, Noh, MM, Jeffree, MS, Ali, RA. SARS-CoV-2 infection of the nervous system: a review of the literature on neurological involvement in novel coronavirus disease (COVID-19). Bosn J Basic Med Sci 2020. https://doi.org/10.17305/bjbms.2020.4860.Search in Google Scholar
9. Padhi, A, Kumar, S, Gupta, E, Saxena, SK. Laboratory diagnosis of novel coronavirus disease 2019 (COVID-19) infection. Singapore: Springer; 2020:95–107 pp.10.1007/978-981-15-4814-7_9Search in Google Scholar
10. Pormohammad, A, Ghorbani, S, Baradaran, B, Khatami, A, Turner, R, Mansournia, MA, et al.. Clinical characteristics, laboratory findings, radiographic signs and outcomes of 61,742 patients with confirmed COVID-19 infection: a systematic review and meta-analysis. Microb Pathog 2020:104390. https://doi.org/10.1016/j.micpath.2020.104390.Search in Google Scholar
11. Mousavizadeh, L, Ghasemi, S. Genotype and phenotype of COVID-19: their roles in pathogenesis. J Microbiol Immunol Infect 2020. https://doi.org/10.1016/j.jmii.2020.03.022 [Epub ahead of print].Search in Google Scholar
12. Liu, YC, Kuo, RL, Shih, SR. COVID-19: the first documented coronavirus pandemic in history. Biomed J 2020;43:328–33.10.1016/j.bj.2020.04.007Search in Google Scholar PubMed PubMed Central
13. Callaway, E, Ledford, H, Mallapaty, S. Six months of coronavirus: the mysteries scientists are still racing to solve. Nature 2020;583:178–9. https://doi.org/10.1038/d41586-020-01989-z.Search in Google Scholar
14. Soy, M, Keser, G, Atagündüz, P, Tabak, F, Atagündüz, I, Kayhan, S. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol 2020:1. https://doi.org/10.1007/s10067-020-05190-5.Search in Google Scholar
15. Henderson, LA, Canna, SW, Schulert, GS, Volpi, S, Lee, PY, Kernan, KF, et al.. On the alert for cytokine storm: immunopathology in COVID‐19. Arthritis Rheumatol 2020;72:1059–63.10.1002/art.41285Search in Google Scholar PubMed PubMed Central
16. Ye, Q, Wang, B, Mao, J. The pathogenesis and treatment of theCytokine Storm’in COVID-19. J Infect 2020;80:607–13. https://doi.org/10.1016/j.jinf.2020.03.037.Search in Google Scholar
17. Connors, JM, Levy, JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood 2020;135:2033–40. https://doi.org/10.1182/blood.2020006000.Search in Google Scholar
18. Rokkas, T. Gastrointestinal involvement in COVID-19: a systematic review and meta-analysis. Ann Gastroenterol 2020;33:355. https://doi.org/10.20524/aog.2020.0506.Search in Google Scholar
19. Su, S, Shen, J, Zhu, L, Qiu, Y, He, JS, Tan, JY, et al.. COVID19? Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges. Therap Adv Gastroenterol 2020;13:1756284820934626. https://doi.org/10.1177/1756284820934626.Search in Google Scholar
20. Li, LY, Wu, W, Chen, S, Gu, JW, Li, XL, Song, HJ, et al.. Digestive system involvement of novel coronavirus infection: prevention and control infection from a gastroenterology perspective. J Digest Dis 2020;21:199–204. https://doi.org/10.1111/1751-2980.12862.Search in Google Scholar
21. Baig, AM, Khaleeq, A, Ali, U, Syeda, H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 2020;11:995–8. https://doi.org/10.1021/acschemneuro.0c00122.Search in Google Scholar
22. Volpato, S, Landi, F, Incalzi, RA. A frail health care system for an old population: lesson form the COVID-19 outbreak in Italy. J Gerontol: Ser A 2020;75:e126–7.10.1093/gerona/glaa087Search in Google Scholar
23. Mallapaty, S. The coronavirus is most deadly if you are older and male - new data reveal the risks. Nature 2020;585:16–7. https://doi.org/10.1038/d41586-020-02483-2.Search in Google Scholar
24. D’Adamo, H, Yoshikawa, T, Ouslander, JG. Coronavirus disease 2019 in geriatrics and long‐term care: the ABCDs of COVID‐19. J Am Geriatr Soc 2020;68:91. https://doi.org/10.1111/jgs.16445.Search in Google Scholar
25. Boccardi, V, Ruggiero, C, Mecocci, P. COVID-19: A geriatric emergency. Geriatrics 2020;5:24.10.3390/geriatrics5020024Search in Google Scholar
26. Tay, HS, Harwood, R. Atypical presentation of COVID-19 in a frail older person. Age Ageing 2020;49:523–4.10.1093/ageing/afaa068Search in Google Scholar
27. Liu, K, Chen, Y, Lin, R, Han, K. Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients. J Infect 2020;80:e14–8.10.1016/j.jinf.2020.03.005Search in Google Scholar
28. Nicol, GE, Piccirillo, JF, Mulsant, BH, Lenze, EJ. Action at a distance: geriatric research during a pandemic. J Am Geriatr Soc 2020;68:922–5.10.1111/jgs.16443Search in Google Scholar
29. Armitage, R, Nellums, LB. COVID-19 and the consequences of isolating the elderly. The Lancet Public Health 2020;5:e256. https://doi.org/10.1016/s2468-2667(20)30061-x.Search in Google Scholar
30. World Health Organization. COVID-19 vaccines. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines [Accessed 18 Jan 2021].Search in Google Scholar
31. Kaur, SP, Gupta, V. COVID-19 Vaccine: a comprehensive status report. Virus Res 2020;288:198114. https://doi.org/10.1016/j.virusres.2020.198114.Search in Google Scholar
32. World Health Organization. Who can take the Pfizer-BioNTech COVID-19 vaccine? Available from: https://www.who.int/news-room/feature-stories/detail/who-can-take-the-pfizer-biontech-covid-19--vaccine [Accessed 18 Jan 2021].Search in Google Scholar
33. Koff, WC, Williams, MA. Covid-19 and immunity in aging populations—a new research agenda. N Engl J Med 2020;383:804–5.10.1056/NEJMp2006761Search in Google Scholar
34. Jean, SS, Lee, PI, Hsueh, PR. Treatment options for COVID-19: the reality and challenges. J Microbiol Immunol Infect 2020.10.1016/j.jmii.2020.03.034Search in Google Scholar
35. Mitjà, O, Clotet, B. Use of antiviral drugs to reduce COVID-19 transmission. The Lancet Global Health 2020;8:e639–40. https://doi.org/10.1016/s2214-109x(20)30114-5.Search in Google Scholar
36. Şimşek, YS, Ünal, S. Antiviral treatment of COVID-19. Turk Med J Sci 2020;50:611–9.10.3906/sag-2004-145Search in Google Scholar PubMed PubMed Central
37. Bloch, EM, Shoham, S, Casadevall, A, Sachais, BS, Shaz, B, Winters, JL, et al.. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest 2020;130:2757–65. https://doi.org/10.1172/jci138745.Search in Google Scholar
38. Rajendran, K, Narayanasamy, K, Rangarajan, J, Rathinam, J, Natarajan, M, Ramachandran, A. Convalescent plasma transfusion for the treatment of COVID‐19: systematic review. J Med Virol 2020;92:1475–83.10.1002/jmv.25961Search in Google Scholar PubMed PubMed Central
© 2021 Walter de Gruyter GmbH, Berlin/Boston
